Postoperative complications in patients with portal vein thrombosis after liver transplantation: Eva

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:muniao090908
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To study the postoperative complications in patients with preoperative portal vein thrombosis (PVT)undergoing liver transplantation (LT) and to evaluate the complications with Doppler ultrasonography.METHODS: Retrospective studies were performed on 284 patients undergoing LT (286 LT) with respect to pre- and postoperative clinical data and Doppler ultrasonography. According to the presence and grade of preoperative PVT, 286 LTs were divided into three groups: complete PVT (c-PVT), partial PVT (p-PVT) and non-PVT, with 22, 30 and 234 LTs, respectively. Analyses were carried out to compare the incidence of early postoperative complications.RESULTS: PVT, inferior vena cava (IVC) thrombosis,hepatic artery thrombosis (HAT) and biliary complications were found postoperatively. All complications were detected by routine Doppler ultrasonography and diagnoses made by ultrasound were confirmed by clinical data or/and other imaging studies. Nine out of 286 LTs had postoperative PVT. The incidence of the c-PVT group was 22.7%, which was higher than that of the p-PVT group (3.3%, P < 0.05) and non-PVT group (1.3%, P < 0.005). No difference was found between the p-PVT and non-PVT groups (P > 0.25).Of the 9 cases with postoperative PVT, recanalizations were achieved in 7 cases after anticoagulation under the guidance of ultrasound, 1 case received portal vein thrombectomy and 1 case died of acute injection. Ten LTs had postoperative IVC thrombosis. The c-PVT group had a higher incidence of IVC thrombosis than the non-PVT group (9.1% vs 2.6%, P < 0.05); no significant difference was found between either the c-PVT and p-PVT groups (9.1% vs 6.7%, P > 0.5) or between the p-PVT and non-PVT groups (P > 0.25). Nine cases with IVC thrombosis were cured by anticoagulation under the guidance of ultrasound, and 1 case gained natural cure without any medical treatment after 2 mo. HAT was found in 2 non-PVT cases, giving a rate of 0.7%among 286 LTs. Biliary complications were seen in 12LTs. The incidence of biliary complications in the c-PVT,p-PVT and non-PVT groups was 9.1%, 3.3% and 4.3%,respectively (P > 0.25 for all), among which 2 stenosis led retransplantations and others were controlled by relative therapy.CONCLUSION: C-PVT patients tend to have a higher incidence of PVT and IVC thrombosis than non-PVT patients after LT. The incidence of postoperative complications in p-PVT patients does not differ from that of non-PVT patients. A relatively low incidence of HAT was seen in our study. Doppler ultrasonography is a convenient and efficient method for detecting posttransplant complications and plays an important role in guiding treatment.
其他文献
AIM: To investigate the hotspots, direction, and the time course of evolution of hepatitis A virus in the process of consecutive cell culture passage in human K
当前随着人口老龄化以及医疗保健水平的提高,前列腺癌的发病率和检出率正呈现逐年递增的趋势.良性前列腺增生(benign prostatic hyperplasia,BPH)在临床上是男性常见的一种进
期刊
目的:建立同时提取丹参中丹参酮ⅡA与丹酚酸B两种主要活性成分的方法及丹酚酸B的纯化工艺.方法:以丹参酮ⅡA与丹酚酸B的提取率和药效实验中血液流变参数为评价指标,考察最佳
目的:研究使用甲状腺激素进行妊娠期亚临床加减临床治疗中的治疗效果.方法:选取本院自2016年1月—2018年5月期间到本院进行检查的妊娠期亚临床加减的60名患者作为研究对象,并
Objective: To assess anti-psoriatic activity of the methanol extract and the isolated flavonoid quercetin from the rhizome of Smilax china (S. china) Linn. Meth
目的探讨老年手术患者以不同水平的每搏量变异度(SVV)指导液体治疗方案对预后的临床意义。方法选择施行腹部手术的老年患者156例,ASA分级Ⅰ~Ⅱ级。将患者按不同SVV水平进行分组:低SVV组(SVV 3%~6%)、中SVV组(SVV 7%~10%)及高SVV组(SVV 11%~14%),每组52例,按分组不同水平SVV实施不同液体治疗方案。比较三组术中相关指标、术后恢复指标及术后相关并发症。结果低
目的 观察椎体后凸成形术治疗急性老年胸腰椎压缩性骨折疗效.方法 选取我院急性老年胸腰椎压缩性骨折患者50例(2017年3月至2018年6月),患者均给予椎体后凸成形术治疗,观察患
1例53岁男性滤泡性淋巴瘤患者因行R-GDP方案(利妥昔单抗+吉西他滨+地塞米松;21 d为1个周期)化疗第5天出现药源性肾损伤而终止疗程,14 d后出现阴囊水肿,16 d后给予来那度胺10 mg口服、1次/d,并于使用该药第5天行R-FC方案(利妥昔单抗+氟达拉滨+环磷酰胺;28 d为1个周期)化疗。使用来那度胺第17天,患者阴囊水肿缓解,但出现粒细胞缺乏[白细胞计数(WBC)1.8×109/L
目的:探索二甲双胍药物应用于妊娠期糖尿病患者治疗中的临床效果,并对此进行相关的细化研究.方法:将本院2016年1月—2018年5月期间到本院进行检测确诊为妊娠期糖尿病(GDM)的6
AIM: To investigate if the nucleoside analogue lamivudine (LAM), a potent inhibitor of HBV replication,could restore the function of dendritic cells derived fro